3PD Top 200 drugs - Fall 2024 - Pain/musculoskeletal agents

studied byStudied by 0 people
0.0(0)
learn
LearnA personalized and smart learning plan
exam
Practice TestTake a test on your terms and definitions
spaced repetition
Spaced RepetitionScientifically backed study method
heart puzzle
Matching GameHow quick can you match all your cards?
flashcards
FlashcardsStudy terms and definitions

1 / 279

encourage image

There's no tags or description

Looks like no one added any tags here yet for you.

280 Terms

1

Acetaminophen; Hydrocodone brand name

Norco, Lortab, Vicodin, Lorcet, Hysingla ER

New cards
2

Acetaminophen; Hydrocodone Therapeutic Class

Opioid Analgesic. C-II

New cards
3

Acetaminophen; Hydrocodone FDA Labeled indications

Pain, severe

New cards
4

Acetaminophen; Hydrocodone MOA

binds to opiate receptors, resulting in altered perception of pain.

New cards
5

Acetaminophen; Hydrocodone Box Warnings

Addiction, abuse, misuse, REMS, respiratory depression, accidental ingestion, neonatal opioid withdrawal, alcohol, CYP3A4/5 interactions, hepatotoxicity, concurrent use with benzodiazepines

New cards
6

Acetaminophen; Hydrocodone ADRs

Constipation, GI distress, somnolence

New cards
7

Acetaminophen; Hydrocodone Counseling Points

Use a stool softener and/or laxative for preventing constipation with chronic use.

May cause drowsiness; avoid driving or other tasks requiring motor coordination.

Avoid alcohol and other CNS depressants.

New cards
8

Baclofen Brand Name

Lioresal, Ozobax, Fleqsuvy

New cards
9

Baclofen Therapeutic class

Centrally Acting Skeletal Muscle Relaxant

New cards
10

Baclofen FDA labeled indications

Spasticity

New cards
11

Baclofen MOA

inhibits both monosynaptic and polysynaptic reflexes at the spinal level, possibly by hyperpolarization of afferent terminals, although actions at supraspinal sites may also occur and contribute to its clinical effect. It is an analogue of γ-aminobutyric acid (GABA)

New cards
12

Baclofen Box warnings

Avoid abrupt discontinuation of oral or intrathecal product

New cards
13

Baclofen ADRs

Nausea, asthenia, dizziness, somnolence, confusion

New cards
14

Baclofen Key counseling points

Because of the possibility of sedation, be cautioned regarding the operation of motor vehicles or dangerous machinery while taking.

be cautioned that the CNS effects may be additive to those of alcohol and other CNS depressants.

New cards
15

Burpenorphine/Naloxone brand name

Suboxone, Zubsolv

New cards
16

Burpenorphine/Naloxone Therapeutic class

Opioid Partial Agonist and Antagonist Combination. C-III

New cards
17

Burpenorphine/Naloxone FDA labeled indications

Opioid use disorder

New cards
18

Buprenorphine/Naloxone MOA

Bup: μ-opioid receptor partial agonist and alpha-opioid receptor antagonist.

Naloxone: μ-opioid receptor antagonist that causes opioid withdrawal when injected parenterally and is included in the formulation to reduce the risk of abuse.

New cards
19

Burpenorphine/Naloxone Box warnings

None

New cards
20

Buprenorphine/Naloxone ADRs

Vasodilation, sweating, headaches, insomnia, constipation, GI distress, opioid withdrawal, dizziness

New cards
21

Burpenorphine/Naloxone counseling points

Use a stool softener and/or laxative for preventing constipation.

May cause drowsiness; avoid driving or other tasks requiring motor coordination. Avoid alcohol and other CNS depressants.

Do not crush or swallow the sublingual tablet. Place the tablet under the tongue until it is dissolved. If you take ≥2 tablets at a time, place all of the tablets under the tongue together. If this is uncomfortable, place 2 tablets at a time under the tongue and repeat the process until all tablets have been taken. If you are using the sublingual film, place the film under the tongue until it is dissolved. If you need to take an additional film, place the new film on the opposite side from the first film. Do not chew, swallow, or move the film after placing it under the tongue.

New cards
22

Carisoprodol brand name

Soma, Vanadom

New cards
23

Carisoprodol therapeutic class

Centrally Acting Skeletal Muscle Relaxant. C-IV

New cards
24

Carisoprodol FDA labeled indications

Disorder of musculoskeletal system

New cards
25

Carisoprodol MOA

blocks interneuronal activity in descending reticular formation and spinal cord, resulting in muscle relaxation.

New cards
26

Carisoprodol Box Warnings

none

New cards
27

Carisoprodol ADRs

Drowsiness, dizziness

New cards
28

Carisoprodol counseling points

avoid consuming alcohol.

avoid activities requiring mental alertness or coordination until drug effects are known, as drug may cause dizziness or sedative effects.

Patients withdrawing from prolonged therapy should be monitored carefully for withdrawal symptoms, including seizures.

New cards
29

Celecoxib brand name

Celebrex

New cards
30

Celecoxib Class

Cyclooxygenase-2 (COX-2) Inhibitor - NSAID

New cards
31

Celecoxib FDA labeled indications

Osteoarthritis

Rheumatoid arthritis

Ankylosing spondylitis

Acute pain, primary dysmenorrhea

New cards
32

Celecoxib MOA

Inhibition of the COX-2 enzyme isoform is thought to be responsible for the anti-inflammatory effects

New cards
33

Celecoxib Box warnings

Cardiotoxicity, CABG

New cards
34

Celecoxib ADRs

HTN, headaches, GI distress, diarrhea

New cards
35

Celecoxib counseling Points

May take with food or milk to decrease GI upset.

May open capsule and pour into a teaspoon of applesauce.

New cards
36

Codeine with Acetaminophen brand name

Tylenol with Codeine

New cards
37

Codeine with Acetaminophen Class

Opioid. C-II (when in combination with acetaminophen, C-III for tablets, C-V for liquid)

New cards
38

Codeine with Acetaminophen FDA labeled indications

Pain

New cards
39

Codeine with Acetaminophen MOA

is 3-methylmorphine, a phenanthrene opioid with very low affinity for opioid receptors. Its analgesic activity appears to result from conversion to morphine.

New cards
40

Codeine with Acetaminophen box warnings

Abuse, REMs, respiratory depression, accidental ingestion, CYP2D6 in children, neonatal withdrawal syndrome, interactions with CYP3A4/5, 2D6, avoid concomitant benzodiazepines and CNS depressants

New cards
41

Codeine with Acetaminophen ADRs

Nausea, vomiting, constipation, somnolence

New cards
42

Codeine with Acetaminophen counseling points

If using chronically, use laxative for preventing constipation.

May cause drowsiness; avoid driving or other tasks requiring motor coordination. Avoid alcohol.

New cards
43

Cyclobenzaprine Hydrochloride brand name

Flexeril, Amrix, Fexmid

New cards
44

Cyclobenzaprine Class

Centrally Acting Skeletal Muscle Relaxant

New cards
45

Cyclobenzaprine FDA labeled indications

Skeletal muscle spasm

New cards
46

Cyclobenzaprine MOA

relieves skeletal muscle spasm of local origin without interfering with muscle function. It is ineffective in muscle spasm due to CNS disease. Evidence suggests that the net effect is a reduction in tonic motor activity, influencing both gamma (γ) and alpha (α) motor systems.

New cards
47

Cyclobenzaprine Box warning

none

New cards
48

Cyclobenzaprine ADRs

Xerostomia, headache, dizziness, drowsiness

New cards
49

Cyclobenzaprine counseling points

avoid activities requiring mental alertness or coordination until drug effects are known, as drug may cause dizziness or sedative effects.

Take extended-release capsule same time each day.

New cards
50

Diclofenac brand name

Voltaren, Voltaren XR

New cards
51

Diclofenac class

NSAID

New cards
52

Diclofenac FDA labeled indications

Pain

Dysmenorrhea

Migraine

Osteoarthritis

Rheumatoid arthritis

Ankylosing spondylitis

New cards
53

Diclofenac MOA

Nonselective inhibitor of cyclo-oxygenase-1 (COX-1) and cyclo-oxygenase-2 (COX-2).

New cards
54

Diclofenac box warning

Cardiovascular, GI risk, CABG

New cards
55

Diclofenac ADRS

Headaches, GI distress

New cards
56

Diclofenac counseling points

Take with food or milk to decrease GI upset.

New cards
57

Fentanyl (Transdermal) brand name

Duragesic

New cards
58

Fentanyl Class

Opioid Analgesic. C-II

New cards
59

Fentanyl FDA labeled indications

Pain, chronic

Chronic cancer pain, management of breakthrough

New cards
60

Fentanyl MOA

phenylpiperidine opioid agonist with predominant effects on the mu-opioid receptor and is about 50-100 times more potent as an analgesic than morphine.

New cards
61

Fentanyl box warnings

Respiratory depression; addiction, CYP3A4/5 interactions, fatalities in children; formulations not interchangeable; care with disposal; REMS program; concurrent use with benzodiazepines or other CNS depressants, neonatal withdrawal, medication errors, heat exposure

New cards
62

Fentanyl ADRs

Application site reactions, sweating, constipation, GI distress, confusion, headache, anxiety, urinary retention, fatigue

New cards
63

Fentanyl counseling points

Use a laxative for preventing constipation.

May cause drowsiness; avoid driving or other tasks requiring motor coordination.

Avoid alcohol and other CNS depressants.

Apply to clean, dry skin. Skin breaks may increase absorption.

Remove old patch when new patch applied.

Febrile patients may have increased absorption. Monitor carefully.

New cards
64

Hydrocodone Brand Name

Norco, Lorcet, Vicodin, Hysingla ER

New cards
65

Hydrocodone Therapeutic Class

Opioid Analgesic. C-II

New cards
66

Hydrocodone FDA Labeled indications

Pain, severe

New cards
67

Hydrocodone MOA

binds to opiate receptors, resulting in altered perception of pain.

New cards
68

Hydrocodone Box warning

Addiction, abuse, misuse, REMS, respiratory depression, accidental ingestion, neonatal opioid withdrawal, alcohol, CYP3A4/5 interactions, hepatotoxicity, concurrent use with benzodiazepines

New cards
69

Hydrocodone ADRs

Constipation, GI distress, somnolence

New cards
70

Hydrocodone Counseling Points

Use a stool softener and/or laxative for preventing constipation with chronic use.

May cause drowsiness; avoid driving or other tasks requiring motor coordination.

Avoid alcohol and other CNS depressants.

New cards
71

Hydrocortisone rectal brand name

Anusol-HC, Proctosol-HC

New cards
72

Hydrocortisone rectal FDA Labeled indications

Skin disorders, corticosteroid responsive

Ulcerative colitis and Proctitis

New cards
73

Hydrocortisone Therapeutic Classification

Topical Corticosteroid

New cards
74

Hydrocortisone MOA

anti-inflammatory, antipruritic, and vasoconstrictive properties, are thought to act by the induction of phospholipase A2-inhibitory proteins, lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor, arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2.

New cards
75

Hydrocortisone Box warning

None

New cards
76

Hydrocortisone ADRs

None

New cards
77

Hydrocortisone counseling points

Apply thin layer to affected area of skin. Skin should be clean and intact at site of application. Avoid contact with eyes and do not ingest by mouth. Avoid occlusive dressings or tight-fitting clothes over site of administration. Wash hands after application.

New cards
78

Ibuprofen brand name

Motrin

New cards
79

Ibuprofen therapeutic class

NSAID

New cards
80

Ibuprofen FDA labeled indications

Fever

Pain, headache

Osteoarthritis or rheumatoid arthritis

Juvenile rheumatoid arthritis

New cards
81

Ibuprofen Box warning

Cardiovascular events, GI toxicity, CABG

New cards
82

Ibuprofen MOA

Nonselective inhibitor of cyclo-oxygenase-1 (COX-1) and cyclo-oxygenase-2 (COX-2), and reversibly alters platelet function and prolongs bleeding time.

New cards
83

Ibuprofen Counseling Points

Take with food or milk to decrease GI upset.

Counsel patients with heart failure to avoid NSAIDs as they may cause fluid retention which can exacerbate heart failure.

New cards
84

Ibuprofen common ADRs

None

New cards
85

Lidocaine Transdermal brand name

Lidoderm

New cards
86

Lidocaine therapeutic class

Local Anesthetic

New cards
87

Lidocaine FDA Labeled indications

Postherpetic neuralgia and localized pain

New cards
88

Lidocaine MOA

amide-type local anesthetic agent and is suggested to stabilize neuronal membranes by inhibiting the ionic fluxes required for the initiation and conduction of impulses

New cards
89

Lidocaine Box warning

None

New cards
90

Lidocaine ADRs

Skin irritation, somnolence

New cards
91

Lidocaine counseling points

Instruct patients on the appropriate application process. Leave patches on skin for no >12 h within a 24-h period

Caution patients to administer only as directed, to intact skin, without covering with occlusive dressing or tight clothes.

New cards
92

Meloxicam brand name

Mobic

New cards
93

Meloxicam Therapeutic Class

NSAID

New cards
94

Meloxicam FDA Labeled indications

Osteoarthritis

Rheumatoid arthritis

Juvenile rheumatoid arthritis

New cards
95

Meloxicam MOA

Nonselective inhibitor of COX-1 and COX-2 which results in decreased formation of prostaglandin precursors; has antipyretic, analgesic, and anti-inflammatory properties; reversibly alters platelet function and prolongs bleeding time.

New cards
96

Meloxicam Box warning

Cardiovascular thrombotic events, serious GI bleeding and perforation, CABG

New cards
97

Meloxicam ADRs

GI distress

New cards
98

Meloxicam Counseling Points

Take with food or milk to decrease GI upset.

For suspension, shake gently before using.

Avoid use around 20 wk gestation. Pregnant women should consult HCP before using.

New cards
99

Methocarbamol Brand name

Robaxin

New cards
100

Methocarbamol Therapeutic Class

Centrally Acting Skeletal Muscle Relaxant

New cards

Explore top notes

note Note
studied byStudied by 9 people
354 days ago
5.0(1)
note Note
studied byStudied by 22 people
695 days ago
5.0(1)
note Note
studied byStudied by 13 people
956 days ago
5.0(1)
note Note
studied byStudied by 721 people
321 days ago
4.5(2)
note Note
studied byStudied by 11 people
868 days ago
5.0(1)
note Note
studied byStudied by 42 people
868 days ago
5.0(2)
note Note
studied byStudied by 94 people
807 days ago
5.0(1)
note Note
studied byStudied by 221 people
342 days ago
5.0(3)

Explore top flashcards

flashcards Flashcard (22)
studied byStudied by 32 people
518 days ago
5.0(1)
flashcards Flashcard (81)
studied byStudied by 13 people
44 days ago
5.0(1)
flashcards Flashcard (110)
studied byStudied by 37 people
427 days ago
5.0(3)
flashcards Flashcard (97)
studied byStudied by 14 people
820 days ago
5.0(1)
flashcards Flashcard (53)
studied byStudied by 4 people
680 days ago
5.0(1)
flashcards Flashcard (542)
studied byStudied by 32 people
854 days ago
5.0(1)
flashcards Flashcard (78)
studied byStudied by 35 people
462 days ago
5.0(1)
flashcards Flashcard (29)
studied byStudied by 12 people
20 hours ago
4.0(1)
robot